Biotech

All Articles

Lilly, Haya ink $1B biobuck excessive weight contract to search dark genome

.Eli Lilly's hunt for weight problems targets has led it to the darker genome. The Big Pharma has cr...

ArsenalBio raises $325M, pivots away from former lead property

.Toolbox Biosciences is proceeding up. The tissue treatment company has added on $325 million in amm...

Lilly- backed weight reduction biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana use medicine flunks stage 2b, steering Indivior to rethink $100M possibility

.Aelis Farma's chances of getting a quick, positive selection on a $one hundred thousand alternative...

ProKidney halts phase 3 test not needed for cell therapy permission

.ProKidney has actually ceased among a set of stage 3 trials for its own tissue treatment for kidney...

Vaxcyte climbs on 'impressive' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what analysts named "stunning" period 1/2 records for its own 31-valent pneumococc...

Recursion's human brain health condition trial presents scant evidence of efficacy

.Recursion has stumbled with an early examination of its own tech-enabled method to drug exploration...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Call it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning sc...

Praxis epilepsy medicine decreases confiscations in phase 2 hearing

.Practice Precision Medicines has actually scored one more midphase succeed in epilepsy this year, a...

Three officers resign as Dyne posts mixed information for DMD prospect

.After getting away from a professional grip several years back, Dyne Therapeutics has actually unco...